Ying A. Wang

2.6k total citations
11 papers, 417 citations indexed

About

Ying A. Wang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ying A. Wang has authored 11 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Ying A. Wang's work include Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ying A. Wang is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ying A. Wang collaborates with scholars based in United States, Germany and Switzerland. Ying A. Wang's co-authors include L. Adrienne Cupples, Jhanelle E. Gray, Jean‐Luc Canon, Enriqueta Felip, Filippo de Braud, Hiroshige Yoshioka, Wu‐Chou Su, Martin Reck, Sumitra Thongprasert and Tommaso De Pas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ying A. Wang

11 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying A. Wang United States 9 196 166 128 105 52 11 417
K. Nathan Sankar United States 14 269 1.4× 124 0.7× 170 1.3× 80 0.8× 36 0.7× 41 526
Keiichi Kinowaki Japan 11 141 0.7× 142 0.9× 97 0.8× 89 0.8× 50 1.0× 99 479
Corrado Gallo Stampino Italy 12 238 1.2× 183 1.1× 103 0.8× 39 0.4× 32 0.6× 31 419
Eivind Smeland Norway 14 231 1.2× 98 0.6× 195 1.5× 93 0.9× 56 1.1× 22 441
Toshikazu Okaneya Japan 12 124 0.6× 141 0.8× 152 1.2× 53 0.5× 40 0.8× 51 423
Boyang Chang China 12 224 1.1× 142 0.9× 94 0.7× 84 0.8× 34 0.7× 26 458
Katrin Friedbichler Austria 9 158 0.8× 187 1.1× 39 0.3× 114 1.1× 38 0.7× 13 412
Kolette D. Fly United States 8 179 0.9× 93 0.6× 233 1.8× 61 0.6× 23 0.4× 15 460
Ewa Chmielowska Poland 12 251 1.3× 109 0.7× 132 1.0× 46 0.4× 119 2.3× 44 468
Nada Babović Serbia 14 258 1.3× 98 0.6× 114 0.9× 319 3.0× 66 1.3× 34 611

Countries citing papers authored by Ying A. Wang

Since Specialization
Citations

This map shows the geographic impact of Ying A. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying A. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying A. Wang more than expected).

Fields of papers citing papers by Ying A. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying A. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying A. Wang. The network helps show where Ying A. Wang may publish in the future.

Co-authorship network of co-authors of Ying A. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying A. Wang. A scholar is included among the top collaborators of Ying A. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying A. Wang. Ying A. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vienot, Angélique, Déwi Vernerey, Adeline Bouard, et al.. (2025). Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials. Cancer Research Communications. 5(2). 287–294. 2 indexed citations
2.
3.
Fakih, Marwan, Kanwal Raghav, David Chang, et al.. (2021). Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).. Journal of Clinical Oncology. 39(15_suppl). 3560–3560. 52 indexed citations
4.
El-Khoueiry, Anthony B., Richard D. Kim, William Proctor Harris, et al.. (2021). Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 39(15_suppl). 4078–4078. 15 indexed citations
5.
Wong, Connie, Jason Baum, Michael T. Beste, et al.. (2020). Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial. Cancer Research. 80(24). 5597–5605. 63 indexed citations
6.
Soulières, Denis, Lisa Licitra, Ricard Mesı́a, et al.. (2018). Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1. Clinical Cancer Research. 24(11). 2505–2516. 34 indexed citations
7.
Vansteenkiste, Johan, Jean‐Luc Canon, Filippo de Braud, et al.. (2015). Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 10(9). 1319–1327. 123 indexed citations
8.
Burmester, Gerd R, Patrick Durez, Mark C. Genovese, et al.. (2015). Association ofHLA-DRB1alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis. Lara D. Veeken. 55(1). 49–55. 37 indexed citations
9.
Cohen, Kenneth S., Susan Cheng, Martin G. Larson, et al.. (2013). Circulating CD34+ progenitor cell frequency is associated with clinical and genetic factors. Blood. 121(8). e50–e56. 54 indexed citations
10.
Ruiz-Narváez, Edward, Patricia A. Fraser, Julie R. Palmer, et al.. (2011). MHC region and risk of systemic lupus erythematosus in African American women. Human Genetics. 130(6). 807–815. 20 indexed citations
11.
Shaw, Stanley Y., Susan Cheng, L. Adrienne Cupples, et al.. (2011). Genetic and Clinical Correlates of Early-Outgrowth Colony-Forming Units. Circulation Cardiovascular Genetics. 4(3). 296–304. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Nathan Sankar Breakdown of academic impact, for papers by Keiichi Kinowaki Breakdown of academic impact, for papers by Corrado Gallo Stampino Breakdown of academic impact, for papers by Eivind Smeland Breakdown of academic impact, for papers by Toshikazu Okaneya Breakdown of academic impact, for papers by Boyang Chang Breakdown of academic impact, for papers by Katrin Friedbichler Breakdown of academic impact, for papers by Kolette D. Fly Breakdown of academic impact, for papers by Ewa Chmielowska Breakdown of academic impact, for papers by Nada Babović
Rankless by CCL
2026